Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4330648"]The global data is significant. I think the problem is convincing the U.S. docs that the data can be applied to their clinical practice and how. That is a bit more difficult. I am certain there will be some more breakouts and studies at the academic level coming in the next two to three years, probably even an extended release version of the product for better preventative dosing.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4330648"]The global data is significant. I think the problem is convincing the U.S. docs that the data can be applied to their clinical practice and how. That is a bit more difficult. I am certain there will be some more breakouts and studies at the academic level coming in the next two to three years, probably even an extended release version of the product for better preventative dosing.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>